PGNY as reported
Progyny, Inc. reported $1.29B of revenue over the trailing twelve months, +6.6% on the year before. 10 reported series are charted on this page, each one as filed.
$1.29B
Revenue, trailing twelve months · to Q1 2026 · +6.6% against the twelve months before
- Net Income
- $68M
Net Income · +29% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $184M
Free Cash Flow · −5.8% year on year · trailing twelve months to Q1 2026
- Op Margin
- 7.4%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.29B | +6.6% | Q1 2026 |
| Net Income | $68M | +29% | Q1 2026 |
| EPS | $0.77 | +35% | Q1 2026 |
| Gross Margin | 24% | n/a | Q1 2026 |
| Op Margin | 7.4% | n/a | Q1 2026 |
| Net Margin | 5.2% | n/a | Q1 2026 |
| ROE | 12% | n/a | Q1 2026 |
| ROA | 7.9% | n/a | Q1 2026 |
| Free Cash Flow | $184M | −5.8% | Q1 2026 |
| P/E | 34.3 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Progyny, Inc. (PGNY) - Revenue & ProfitRevenue & ProfitProgyny, Inc. (PGNY)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com